Holen Sie sich die Stockscreener-App
26.11
6.61%
1.62
Handel nachbörslich:
25.66
-0.45
-1.72%
Faeth Therapeutics Inc Aktie (FTH) Neueste Nachrichten
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
BTIG Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Faeth Therapeutics CFO Stephenson buys $326,127 in FTH stock By Investing.com - Investing.com Australia
Faeth Therapeutics (FTH) CFO adds 13,634 shares via trust purchases - Stock Titan
Form 4 Faeth Therapeutics, Inc For: 1 July By Investing.com - Investing.com India
Faeth Therapeutics CFO Stephenson buys $326,127 in FTH stock - Investing.com
FTH SEC FilingsFaeth Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition - Stocktwits
FTHFaeth Therapeutics Inc Latest SEC Filings - Finviz
Faeth Therapeutics, Inc.(NasdaqCM:FTH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Faeth Therapeutics, Inc.(NasdaqCM:FTH) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Faeth Therapeutics, Inc.(NasdaqCM: FTH) added to Russell 3000E Growth Benchmark - marketscreener.com
Faeth Therapeutics, Inc.(NasdaqCM: FTH) added to Russell Microcap Index - marketscreener.com
Faeth Therapeutics, Inc.(NasdaqCM: FTH) added to Russell 3000E Value Benchmark - marketscreener.com
Total current assets of Faeth Therapeutics, Inc. – NASDAQ:FTH - TradingView
Faeth Therapeutics CFO Stephenson acquires $401,268 in stock By Investing.com - Investing.com Nigeria
Form 4 Faeth Therapeutics, Inc For: 26 June By Investing.com - Investing.com Australia
Faeth Therapeutics CFO Stephenson acquires $401,268 in stock - Investing.com
Faeth Therapeutics (FTH) CFO adds 15,641 shares via trust purchases - Stock Titan
FTH Initiates Coverage On Faeth Therapeutics -- Price Target Set at $57 - GuruFocus
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Baird Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $57 - Moomoo
Baird Initiates Faeth Therapeutics at Outperform With $57 Price Target - marketscreener.com
Enterprise value to revenue forward of Faeth Therapeutics, Inc. – MUN:4070 - TradingView
Enterprise value to EBIT forward of Faeth Therapeutics, Inc. – MUN:4070 - TradingView
Baird initiates Faeth Therapeutics stock with outperform rating By Investing.com - Investing.com Nigeria
Price to sales forward of Faeth Therapeutics, Inc. – NASDAQ:FTH - TradingView
Baird initiates Faeth Therapeutics stock with outperform rating - Investing.com
Enterprise value to EBITDA forward of Faeth Therapeutics, Inc. – MUN:4070 - TradingView
This Principal Financial Group Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday - Sahm
Price to earnings forward of Faeth Therapeutics, Inc. – NASDAQ:FTH - TradingView
Faeth Therapeutics CEO Anand Parikh buys $55,446 in common stock By Investing.com - Investing.com India
FTH | Faeth Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
Price to book forward of Faeth Therapeutics, Inc. – NASDAQ:FTH - TradingView
FTH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Anand Parikh Increases Stake in Faeth Therapeutics Inc - GuruFocus
Faeth Therapeutics CEO Anand Parikh buys $55,446 in common stock - Investing.com UK
Faeth therapeutics CFO Brian C. Stephenson buys $405,920 in stock - Investing.com UK
Faeth therapeutics CFO Brian C. Stephenson buys $405,920 in stock By Investing.com - Investing.com Nigeria
FAETH THERAPEUTICS INC (FTH) Stock Chart - ChartMill
Form 4 Faeth Therapeutics, Inc For: 24 June By Investing.com - Investing.com Australia
FTH | Faeth Therapeutics, Inc. Common Stock Data, Price & News - Quiver Quantitative
Faeth Therapeutics (FTH) CFO adds 17,413 shares via revocable trust purchases - Stock Titan
Faeth Therapeutics CEO buys shares, exercises options | FTH Insider Trading - Stock Titan
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):